Results 131 to 140 of about 21,255 (259)

Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in Ghana. [PDF]

Appl Health Econ Health Policy
Singh K, Kallson E, Otchi EH, Shah-Rohlfs R, Edzeame JS, Harnischfeger F, Yawson AE, De Allegri M.   +7 more
europepmc   +1 more source

The gardener's dilemma: Biodiversity change in cities and what we can do about it

American Journal of Botany, EarlyView.
Françoise Cardou
wiley   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

Lessons from the pandemic: an interrupted time series analysis of food and non-food household expenditures in Iran. [PDF]

BMC Public Health
Zakeri M, Radfar A, Bayati M, Lankarani KB.   +3 more
europepmc   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Evaluating Honduras' health financing system: a comprehensive application of the WHO Health Financing Progress Matrix. [PDF]

Rev Panam Salud Publica
Alfaro HE, Forsberg BC.
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Economic policy uncertainty and the dynamics of healthcare expenditure in China. [PDF]

Front Public Health
Sui Y, Zhang L, Han S, Yun Q.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Financial burden of noncommunicable diseases on households in Bangladesh: a quasi-experimental analysis using national survey data. [PDF]

Health Econ Rev
Rahman T, Gasbarro D, Alam K.
europepmc   +1 more source